Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
Gastric Cancer. 2012 Sep;15 Suppl 1:S125-37. doi: 10.1007/s10120-011-0088-3. Epub 2011 Oct 28.
Most gastric cancer patients present with advanced stage disease precluding curative surgical treatment. These patients may be considered for palliative resection or bypass in the presence of major symptoms; however, the utility of surgery for non-curative, asymptomatic advanced disease is debated and the appropriate treatment strategy unclear.
To evaluate the non-curative surgical literature to better understand the limitations and benefits of non-curative surgery for advanced gastric cancer.
A literature search for non-curative surgical interventions in gastric cancer was conducted using MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials databases from 1 January 1985 to 1 December 2009. All abstracts were independently rated for relevance by a minimum of two reviewers. Outcomes of interest were procedure-related morbidity, mortality, and survival.
Fifty-nine articles were included; the majority were retrospective, single institution case series. Definitions describing the treatment intent for gastrectomy were incomplete in most studies. Only five were truly performed with relief of symptoms as the primary indication for surgery, while the majority were considered non-curative or not otherwise specified. High rates of procedure-related morbidity and mortality were demonstrated for all surgeries across the majority of studies and treatment-intent categories. Median and 1-year survival were poor, and values ranged widely within surgical approaches and across studies.
A lack of transparent documentation of disease burden and symptoms limits the surgical literature in non-curative gastric cancer. Improved survival is not evident for all patients receiving non-curative gastrectomy. Further prospective research is required to determine the optimal intervention for palliative gastric cancer patients.
大多数胃癌患者在确诊时已处于晚期,无法进行根治性手术治疗。对于存在严重症状的患者,可以考虑姑息性切除或旁路手术;然而,对于无治愈可能且无症状的晚期疾病,手术的作用存在争议,其合适的治疗策略也尚不明确。
评估非治愈性手术治疗胃癌的相关文献,以更好地了解非治愈性手术治疗晚期胃癌的局限性和获益。
通过 MEDLINE、EMBASE 和 Cochrane 对照试验中心注册库,检索 1985 年 1 月 1 日至 2009 年 12 月 1 日期间关于胃癌非治愈性手术干预的文献。所有摘要均由至少两名评审员独立进行相关性评价。主要观察终点为手术相关并发症发生率、死亡率和生存率。
共纳入 59 篇文献,其中大部分为回顾性、单机构病例系列研究。大多数研究对胃切除术的治疗意图定义不完整。仅有 5 篇文献真正将缓解症状作为手术的主要指征,而大多数文献则被认为是非治愈性或未明确说明。在大多数研究和治疗意图分类中,所有手术的围手术期并发症发生率和死亡率均较高。中位生存时间和 1 年生存率均较差,不同手术方式和研究之间的差异较大。
缺乏对疾病负担和症状的透明记录,限制了非治愈性胃癌手术治疗的文献质量。并非所有接受非治愈性胃切除术的患者均能获得生存改善。需要进一步的前瞻性研究,以确定姑息性胃癌患者的最佳干预措施。